ConductScience.org, home

Paper36948143

Therapeutic application of natural products: NAD+ metabolism as potential target.

Guo C and 15 others. Phytomedicine, 2023. Cited by 106 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic application of natural products: NAD+ metabolism as potential target. Papers, record 36948143. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948143

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic application of natural products: NAD+ metabolism as potential target.
PubMed
Journal
Phytomedicine
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
106
iCite
Relative citation ratio, by iCite
14.4
iCite
Revised in PubMed
2025-08-01
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guo CChen
2Huang QQingxia
3Wang YYisa
4Yao YYao
5Li JJing
6Chen JJinjin
7Wu MMingxia
8Zhang ZZepeng
9E MMingyao
10Qi HHongyu
11Ji PPeng
12Liu QQing
13Zhao DDaqing
14Su HHang
15Qi WWenxiu
16Li XXiangyan

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
Humans
Animals
NAD
Neurodegenerative Diseases
Cardiovascular Diseases
Diabetes Mellitus
Neoplasms

Source PubMed

Download CSV of topics

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.

PMIDTitleJournalYearIn PapersSource
42946698Ginsenoside Rb1 alleviates uterine aging via AMPK-mediated mTOR inactivation.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42946698PubMed
42737604Computational Identification of New Dual PAK4 and NAMPT Inhibitors.Int J Mol Sci2026https://conductscience.org/library/papers/42737604PubMed
42718913Ginsenoside Rb1: From basic mechanisms to therapeutic applications in diabetic complications.J Ginseng Res2026https://conductscience.org/library/papers/42718913PubMed
42588202Phycocyanobilin Attenuates Oligomerized Amyloid β-Induced Neuronal Senescence Through SIRT1-Associated Mechanisms.Nutrients2026https://conductscience.org/library/papers/42588202PubMed
42542771The Multitalented Marvels: Exploring the Versatile Potential of Natural Products in Osteosarcoma Treatment.Cancer Inform2026https://conductscience.org/library/papers/42542771PubMed
42266183Encephalopathy: Cause, Pathogenesis, and Treatment.MedComm (2020)2026https://conductscience.org/library/papers/42266183PubMed
42196400Emodin Exerts Dual Hepatoprotective/Hepatotoxic Effects Dependent on Metabolic Microenvironment via Gut-Liver Axis Crosstalk: A Multi-Omics Study in MAFLD and Normal Mice.Int J Mol Sci2026https://conductscience.org/library/papers/42196400PubMed
42174698Organoids: generation strategies, applications, and future challenges.Stem Cell Res Ther2026https://conductscience.org/library/papers/42174698PubMed
42100332Immunomodulatory functions of ginsenosides in skin diseases: molecular mechanisms and therapeutic prospects.Front Pharmacol2026https://conductscience.org/library/papers/42100332PubMed
42045041[Scutellarin improves metabolic dysfunction-associated steatotic liver disease in rats by regulating MMP7 and LCN2].Nan Fang Yi Ke Da Xue Xue Bao2026https://conductscience.org/library/papers/42045041PubMed
41867471Ginsenoside Rg3 Mitigates LPS-Induced Injury in Human Bronchial Epithelial Cells by Restoring Autophagic Flux and Inhibiting the TLR4/NF-κB-Mediated Inflammatory Response.J Inflamm Res2026https://conductscience.org/library/papers/41867471PubMed
41695989Beneficial effects of berberine in the treatment of diabetes and its complications.Front Pharmacol2025https://conductscience.org/library/papers/41695989PubMed
41639935Yishen Gushu formula exerts osteoprotective effects in OVX-Induced PMOP rats: role of ferroptosis Inhibition and iron metabolism correction.Hereditas2026https://conductscience.org/library/papers/41639935PubMed
41626566Pharmacological mechanisms of natural products with antidepressant effects: A focus on the programmed cell death regulation.J Pharm Anal2026https://conductscience.org/library/papers/41626566PubMed
41614825A Novel Integrative Framework for Depression: Combining Network Pharmacology, Artificial Intelligence, and Multi-Omics with a Focus on the Microbiota-Gut-Brain Axis.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41614825PubMed
41550598Ginsenoside Rb1-enhanced decellularized extracellular matrix hydrogels ameliorates mitochondrial dysfunction and cellular aging in sepsis-induced acute lung injury.J Ginseng Res2026https://conductscience.org/library/papers/41550598PubMed
41417293Exploring neuroprotective effects of Chuanzhitongluo capsule on an alzheimer's disease rat model.Metab Brain Dis2025https://conductscience.org/library/papers/41417293PubMed
41409594The role of natural products and traditional Chinese medicine formulas in postpartum depression: mechanism and prospects.Front Pharmacol2025https://conductscience.org/library/papers/41409594PubMed
41356283Anxiolytic Effects of Natural Products: Pathological Mechanisms, Molecular Targets, Therapeutic Prospects.Neuropsychiatr Dis Treat2025https://conductscience.org/library/papers/41356283PubMed
41303405Preventive and Protective Effects of Nicotinamide Adenine Dinucleotide Boosters in Aging and Retinal Diseases.Int J Mol Sci2025https://conductscience.org/library/papers/41303405PubMed

See all 71 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HMOX13162PubTator's text mininghttps://conductscience.org/library/genes/3162NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
NAMPT10135PubTator's text mininghttps://conductscience.org/library/genes/10135NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PPARGC1A10891PubTator's text mininghttps://conductscience.org/library/genes/10891NCBI Gene
PRKAA15562PubTator's text mininghttps://conductscience.org/library/genes/5562NCBI Gene
SIRT123411PubTator's text mininghttps://conductscience.org/library/genes/23411NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36948143

GET https://conductscience.org/api/papers/v1/36948143/cited_by?page=2